{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "51662-1395",
      "generic_name": "LIDOCAINE HCI AND EPINEPHRINE",
      "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst",
      "brand_name": "LIDOCAINE HCI AND EPINEPHRINE",
      "active_ingredients": [
        {
          "name": "LIDOCAINE HYDROCHLORIDE",
          "strength": "10 mg/mL"
        },
        {
          "name": "EPINEPHRINE",
          "strength": "10 ug/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "51662-1395-1",
          "description": "50 mL in 1 VIAL, MULTI-DOSE (51662-1395-1)",
          "marketing_start_date": "20191021",
          "sample": false
        },
        {
          "package_ndc": "51662-1395-3",
          "description": "25 POUCH in 1 CASE (51662-1395-3)  / 1 mL in 1 POUCH (51662-1395-2)",
          "marketing_start_date": "20200428",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "HF Acquisition Co LLC, DBA HealthFirst"
        ],
        "rxcui": [
          "1010751"
        ],
        "spl_set_id": [
          "957506a5-1b09-0736-e053-2995a90a0b63"
        ],
        "nui": [
          "N0000000209",
          "N0000000245",
          "N0000175552",
          "N0000175555",
          "N0000175570",
          "M0003647"
        ],
        "pharm_class_moa": [
          "Adrenergic alpha-Agonists [MoA]",
          "Adrenergic beta-Agonists [MoA]"
        ],
        "pharm_class_epc": [
          "alpha-Adrenergic Agonist [EPC]",
          "beta-Adrenergic Agonist [EPC]",
          "Catecholamine [EPC]"
        ],
        "pharm_class_cs": [
          "Catecholamines [CS]"
        ],
        "unii": [
          "V13007Z41A",
          "YKH834O4BH"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "1250d85d-502f-91ed-e063-6394a90a110b",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "marketing_start_date": "20191021",
      "product_id": "51662-1395_1250d85d-502f-91ed-e063-6394a90a110b",
      "application_number": "ANDA089644",
      "brand_name_base": "LIDOCAINE HCI AND EPINEPHRINE",
      "pharm_class": [
        "Adrenergic alpha-Agonists [MoA]",
        "Adrenergic beta-Agonists [MoA]",
        "Amide Local Anesthetic [EPC]",
        "Amides [CS]",
        "Antiarrhythmic [EPC]",
        "Catecholamine [EPC]",
        "Catecholamines [CS]",
        "Local Anesthesia [PE]",
        "alpha-Adrenergic Agonist [EPC]",
        "beta-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}